Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The EMA perspective on drug approval process in the era of precision medicine

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.02.18
Views: 4040
Rating:

Jorge Camarero - Spanish Agency of Medicines and Medical Services, Spain

Jorge Camarero presents at ecancer's Milan Summit on Precision Medicine 2018 about regulatory challenges in the era or personalised medicine and the European Medicines Agency perspective on the drug approval process.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation